Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia

The incidence of obesity is rising with greater than 40% of the world’s population expected to be overweight or suffering from obesity by 2030. This is alarming because obesity increases mortality rates in patients with various cancer subtypes including leukemia. The survival differences between lea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Miyoung, Hamilton, Jamie A. G., Talekar, Ganesh R., Ross, Anthony J., Michael, Langston, Rupji, Manali, Dwivedi, Bhakti, Raikar, Sunil S., Boss, Jeremy, Scharer, Christopher D., Graham, Douglas K., DeRyckere, Deborah, Porter, Christopher C., Henry, Curtis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894417/
https://www.ncbi.nlm.nih.gov/pubmed/35241678
http://dx.doi.org/10.1038/s41467-022-28839-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894417/
https://www.ncbi.nlm.nih.gov/pubmed/35241678
http://dx.doi.org/10.1038/s41467-022-28839-y

Ejemplares similares